Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes

Jelena Kravarusic, Grazia Aleppo*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


In the last 2 decades, diabetes technology has emerged as a branch of diabetes management thanks to the advent of continuous glucose monitoring (CGM) and increased availability of continuous subcutaneous insulin infusion systems, or insulin pumps. These tools have progressed from rudimentary instruments to sophisticated therapeutic options for advanced diabetes management. This article discusses the available CGM and insulin pump systems and the clinical benefits of their use in adults with type 1 diabetes, intensively insulin-treated type 2 diabetes, and pregnant patients with preexisting diabetes.

Original languageEnglish (US)
Pages (from-to)37-55
Number of pages19
JournalEndocrinology and Metabolism Clinics of North America
Issue number1
StatePublished - Mar 2020


  • Continuous glucose monitoring (CGM)
  • Continuous subcutaneous insulin infusion (CSII)
  • Hybrid closed loop
  • Patch pump
  • Sensor-augmented pump (SAP)

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes'. Together they form a unique fingerprint.

Cite this